Replacing Synthetic Additives with Precision Enzymes
Clean labels without trade-offs: how Arzeda-designed enzymes replace synthetic additives with bio-identical ingredients and resilient supply.
← All posts
Consumers read ingredient panels — and reject what they don't recognize: artificial additives, synthetic emulsifiers, chemical stabilizers. Meanwhile, the natural alternatives depend on crop harvests that climate volatility and geopolitics make less dependable every year. Arzeda's Intelligent Protein Design Technology™ resolves the trade-off: enzymes designed to modify raw, natural ingredients during processing, eliminating the need for chemical additives while creating bio-identical ingredients that are rare and desired by consumers.
The challenge: clean-label manufacturing and supply chain integrity
Remove synthetic additives — mono- and diglycerides, modified food starches, chemical preservatives — and product stability, shelf life, and mouthfeel usually degrade with them. And the traditional fix, natural alternatives, frequently depends on vulnerable harvests from a handful of geographic regions.
The Arzeda solution: enzymatic transformation
Arzeda solves the clean-label trade-off by using hyper-specific enzymes to alter native fats, starches, and proteins directly — achieving the functionality of synthetic additives, naturally.
Native raw substrate → Arzeda designer enzyme → Clean-label functional ingredient
- Additive replacement. Designer enzymes modify nature's molecules in situ, during standard food production — creating natural texture, stability, and moisture retention without requiring additional regulatory compliance.
- Bio-identical molecules. Rare or geographically restricted natural ingredients — such as specialized flavor molecules, natural colors, and high-intensity sweeteners — can be produced locally via precision bioconversion powered by Arzeda's enzymes.
- Supply chain de-risking. By decoupling ingredient supply from agricultural yield fluctuations, brands secure steady, local ingredient sources with consistent pricing and quality.
Proof point: ViaLeaf™ next-generation sweeteners. Arzeda commercialized enzymatic bioconversion of crude stevia extract to enable the production of rare stevia glycosides (such as ViaLeaf™ Reb M) at high purity. These next-generation sweeteners deliver zero-calorie, natural sweetness without bitter lingering notes, supporting healthy blood glucose levels and GLP-1 therapy nutrition.
Commercial impact
The result: transparent, resilient products that align with what consumers expect — and what supply chains can actually deliver.
- Streamlined labeling. Replace multi-word chemical additive lists with simple, recognizable native ingredients modified naturally by enzymes.
- Improved profitability. Manufacturing costs are decreased through the use of low-cost feedstock converted to high-value, rare bio-identical molecules.
- Supply chain de-risking. By decoupling ingredient supply from agricultural yield fluctuations, brands secure steady, local ingredient sources with consistent pricing and quality.
- Health and performance. As GLP-1 therapies reshape how people eat, formulating smaller, more nutrient-dense servings will demand clean-label, enzymatically manufactured ingredients.
Arzeda will be at Future Food-Tech London, September 24–25. If clean-label reformulation is on your roadmap, meet the team there — or start the conversation now.